North East and North Cumbria
ICS Formulary
 
back
4 Central nervous system
04-05-01 Anti-obesity drugs acting on the gastro-intestinal tract

Liraglutide Saxenda®
Formulary

 Saxenda®Red

  • Approved as an option for managing overweight and obesity alongside a reduced-calorie diet and increased physical activity in adults in line with NICE and providing: 
    • it is prescribed in secondary care by a specialist multidisciplinary tier 3 weight management service; and
    • the company provides it according to the commercial arrangement 
Link  NICE TA664: Liraglutide for managing overweight and obesity

Red View adult BNF  View SPC online  View childrens BNF
Orlistat
Formulary
  • Only approved for use in accordance with NICE guidance. 
Link  MHRA Drug Safety Update (March 2014): Orlistat: theoretical interaction with antiretroviral HIV medicines

Green View adult BNF  View SPC online  View childrens BNF